Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Molecular Oncology
|
April 23, 2025
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Noé Herbel, Sophie Postel-Vinay
Biomedicines
|
March 25, 2022
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
Carine Ngo, Sophie Postel-Vinay
Cancer Research
|
March 15, 2022
A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers
Roman M Chabanon, Sophie Postel-Vinay
Bulletin Du Cancer
|
December 5, 2009
[Cancer and spirituality: the young oncologists' point of view]
Sophie Postel-Vinay, Sarah Dumont, Hélène Marijon
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2020
Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
Sophie Postel-Vinay, Christophe Massard, Jean-Charles Soria
Seminars in Cancer Biology
|
October 1, 2019
Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers
Roman M Chabanon, Daphné Morel, Sophie Postel-Vinay
Cancer Discovery
|
February 8, 2017
JAK Mutations as Escape Mechanisms to Anti-PD-1 Therapy
Aurelien Marabelle, Sandrine Aspeslagh, Sophie Postel-Vinay, et al.
Current Opinion in Molecular Therapeutics
|
October 7, 2009
Reovirus: Rationale and clinical trial update
Rohit Lal, Dean Harris, Sophie Postel-Vinay, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 28, 2026
Novel Synthetic Lethal Therapeutic Strategies in Precision Oncology
Timothy A Yap, Fiona Simpkins, Marie Porte, et al.
Seminars in Cancer Biology
|
December 28, 2019
Understanding genetic determinants of resistance to immune checkpoint blockers
Sandrine Aspeslagh, Roman M Chabanon, Stéphane Champiat, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Molecular Oncology
|
April 23, 2025
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?
Noé Herbel, Sophie Postel-Vinay
Biomedicines
|
March 25, 2022
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
Carine Ngo, Sophie Postel-Vinay
Cancer Research
|
March 15, 2022
A Novel Synthetic Lethal Approach to Target MYC-Driven Cancers
Roman M Chabanon, Sophie Postel-Vinay
Bulletin Du Cancer
|
December 5, 2009
[Cancer and spirituality: the young oncologists' point of view]
Sophie Postel-Vinay, Sarah Dumont, Hélène Marijon
European Journal of Cancer (Oxford, England : 1990)
|
August 18, 2020
Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
Sophie Postel-Vinay, Christophe Massard, Jean-Charles Soria
Seminars in Cancer Biology
|
October 1, 2019
Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers
Roman M Chabanon, Daphné Morel, Sophie Postel-Vinay
Cancer Discovery
|
February 8, 2017
JAK Mutations as Escape Mechanisms to Anti-PD-1 Therapy
Aurelien Marabelle, Sandrine Aspeslagh, Sophie Postel-Vinay, et al.
Current Opinion in Molecular Therapeutics
|
October 7, 2009
Reovirus: Rationale and clinical trial update
Rohit Lal, Dean Harris, Sophie Postel-Vinay, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 28, 2026
Novel Synthetic Lethal Therapeutic Strategies in Precision Oncology
Timothy A Yap, Fiona Simpkins, Marie Porte, et al.
Seminars in Cancer Biology
|
December 28, 2019
Understanding genetic determinants of resistance to immune checkpoint blockers
Sandrine Aspeslagh, Roman M Chabanon, Stéphane Champiat, et al.
Page
of 11